References and Notes
-
1a
Rodriguez AD.
Ramirez C.
Rodriguez II.
Gonzales E.
Org.
Lett.
1999,
1:
527
-
1b
Kobayashi J.
Madono T.
Shigemori H.
Tetrahedron
Lett.
1995,
36:
5589
-
1c
Sun LQ.
Chen J.
Bruce M.
Deskus JA.
Epperson JR.
Takaki K.
Johnson G.
Iben L.
Mahle
CD.
Ryan E.
Xu C.
Bioorg.
Med. Chem. Lett.
2004,
14:
3799
-
1d
Paramshivappa R.
Kumar PP.
Subba Rao
PV.
Srinivase Rao A.
Bioorg. Med. Chem. Lett.
2003,
13:
657
-
1e
Kumar D.
Jacob MR.
Reynolds MB.
Kerwin SM.
Bioorg.
Med. Chem.
2002,
10:
3997
-
1f
Lopez-Tudanca PL.
Labeaga L.
Innerarity A.
Alonso-Cires L.
Tapia I.
Mosquera R.
Orjales A.
Bioorg. Med. Chem.
2003,
11:
2709
-
2a
Yildiz-Oren I.
Yalcin I.
Aki-Sener E.
Ucarturk N.
Eur.
J. Med. Chem.
2004,
39:
291
-
2b
Tekiner-Gulbas B.
Temiz-Arpaci O.
Yildiz I.
Aki-Sener E.
Yalcin I.
SAR QSAR Environ Res.
2006,
17:
121
-
2c
Clark RL.
Pessolano AA.
Witzel B.
Lanza T.
Shen TY.
J. Med. Chem.
1978,
21:
1158
-
2d
Boger DL.
Miyauchi H.
Du W.
Hardouin C.
Fecik RA.
Cheng H.
Hwang I.
Hedrick MP.
Leung D.
Acevedo O.
Guimarães CRW.
Jorgensen WL.
Cravatt BF.
J. Med. Chem.
2005,
48:
1849
-
2e
Deng JZ.
McMasters DR.
Rabbat PMA.
Williams PD.
Coburn CA.
Yan YW.
Kuo LC.
Lewis SD.
Lucas BJ.
Krueger JA.
Strulovici B.
Vacca JP.
Lylea TA.
Burgeya CS.
Bioorg. Med. Chem.
Lett.
2005,
15:
4411
-
2f
Walczynński K.
Zuiderveld OP.
Timmerman H.
Eur. J. Med. Chem.
2005,
15
-
3a
Doise M.
Dennin F.
Blondeau D.
Sliwa H.
Tetrahedron
Lett.
1990,
31:
1155
-
3b
Doise M.
Blondeau D.
Sliwa H.
Synth.
Commun.
1992,
22:
2891
-
3c
Myllymäki MJ.
Koskinen AMP.
Tetrahedron
Lett.
2007,
48:
2295
-
3d
Heuser S.
Keenanb M.
Weichert
AG.
Tetrahedron Lett.
2005,
46:
9001
-
3e
Phoon CW.
Ng PY.
Ting AE.
Yeob SL.
Sima MM.
Bioorg. Med. Chem. Lett.
2001,
11:
1647
-
4a
Flouzat C.
Guillaumet G.
Synthesis
1990,
64
-
4b
Walczynński K.
Zuiderveld OP.
Timmerman H.
Eur. J. Med. Chem.
2005,
40:
15
-
4c
Garnier E.
Blanchard S.
Rodriguez I.
Jarry C.
Léger J.-M.
Caubère P.
Guillaumet G.
Synthesis
2003,
2033
- 5
Altenhoff G.
Glorius F.
Adv. Synth. Catal.
2004,
346:
1661
-
6a
Ley SV.
Thomas AW.
Angew.
Chem. Int. Ed.
2003,
42:
5400
-
6b
Kunz K.
Scholz U.
Ganzer D.
Synlett
2003,
2428
-
6c
Finet JP.
Fedorov AY.
Combes S.
Boyer G.
Curr. Org.
Chem.
2002,
6:
597
- 7
Evindar G.
Batey RA.
J. Org. Chem.
2006,
71:
1802
8
Typical Procedure
for the Synthesis and Purification of 3a
To a mixture
of 2a (2.0 mmol), CuI (0.1 mmol), N,N′-dimethylethylenediamine
(0.2 mmol), and K2CO3 (4.0 mmol) was added
dry toluene (5.0 mL) under a nitrogen atmosphere. The reaction was
refluxed for 12 h and then allowed to cool to r.t. The crude mixture
was added to 10 mL H2O and then was extracted by CH2Cl2 (2 × 20
mL). The organic layer was dried over anhyd Na2SO4 and concentrated
in vacuo to give the crude product, which was further purified by
flash chromatography over silica gel column with PE-EtOAc
(5:1) to give the pure product 3a.
9
Selected Spectral
Data
Compound 3a: mp 101-102 ˚C. R
f
= 0.55
(EtOAc-PE, 1:2). IR (KBr): 2913, 1617, 1544 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 8.38
(dd, J = 5.1,
1.5 Hz, 1 H), 8.34 (d, J = 1.5 Hz,
1 H), 8.34 (d, J = 2.1
Hz, 1 H), 8.10 (dd, J = 7.8,
1.5 Hz, 1 H), 7.55-7.62 (m, 3 H), 7.36-7.41 (m,
1 H). MS (EI):
m/z = 196 [M]+.
Anal. Calcd for C12H8N2O: C, 73.46;
H, 4.11; N, 14.28. Found: C, 73.46; H, 4.43; N, 14.18.
Compound 3i: mp 79-81 ˚C. R
f
= 0.38
(EtOAc-PE, 1:2). IR (KBr): 2924, 1602, 1523 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 8.35
(dd, J = 4.2,
1.5 Hz, 1 H), 8.21 (dd, J = 7.8,
1.5 Hz, 1 H), 8.12 (dd, J = 7.8,
1.5 Hz, 1 H), 7.53-7.56 (m, 1 H), 7.32-7.37 (m,
1 H), 7.10-7.16 (m, 2 H), 4.05 (s, 3 H). MS (EI): m/z = 226 [M]+.
Anal. Calcd for C13H10N2O2:
C, 69.02; H, 4.46; N, 12.38. Found: C, 68.67; H, 4.34; N, 12.38.
Compound 3k: mp 172-174 ˚C. R
f
= 0.42
(EtOAc-PE, 1:2). IR (KBr): 1496, 1620, 1223 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 8.34
(dd, J = 4.5,
1.5 Hz, 1 H), 8.05 (dd, J = 7.8, 1.5
Hz, 1 H), 7.54 (s, 2 H), 7.33-7.37 (m, 1 H), 4.04 (s, 9
H). MS (EI): m/z = 286 [M]+.
Anal. Calcd for C15H14N2O4:
C, 62.93; H, 4.93; N, 9.79; Found: C, 63.12; H, 4.74; N, 9.78.
Compound 6a: mp 163-164 ˚C. R
f
= 0.38
(EtOAc-PE, 1:2). IR (KBr): 2920, 1670, 1580 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 8.56
(s, 1 H), 8.46 (dd, J = 1.5,
7.2 Hz, 2 H), 7.81 (s, 1 H), 7.75-7.65 (m, 3 H), 2.65 (s,
3 H). ¹³C NMR (75 MHz, CDCl3): δ = 165.1,
154.4, 147.3, 132.3, 130.6, 129.0, 128.0, 126.7, 118.5, 18.9. ESI-MS: m/z = 211 [M+ + 1]. Anal.
Calcd for C13H10N2O: C, 74.27;
H, 4.79; N, 13.33. Found: C, 74.05; H, 4.77; N, 13.28.
Compound 6b: mp 165-167 ˚C. R
f
= 0.35
(EtOAc-PE, 1:2). IR (KBr): 2918, 1620, 1550 cm-¹.¹H
NMR (300 MHz, CDCl3): δ = 8.57
(s, 1 H), 8.32 (d, J = 8.4
Hz, 2 H), 8.01 (d, J = 8.3
Hz, 2 H), 7.84 (s, 1 H), 3.95 (s, 1 H), 2.64 (s, 3 H). ESI-MS: m/z = 241 [M+ + 1].
Anal. Calcd for C13H10N2O: C, 69.99;
H, 5.03; N, 11.66. Found: C, 69.78; H, 4.98; N, 11.69.
Compound 6c: mp 193-194 ˚C. R
f
= 0.32
(EtOAc-PE, 1:2). IR (KBr): 2918, 1610, 1560 cm-¹.¹H
NMR (300 MHz, CDCl3): δ = 8.59
(s, 1 H), 8.16 (d, J = 8.7
Hz, 2 H), 8.04 (d, J = 8.1
Hz, 2 H), 7.84 (s, 1 H), 2.64 (s, 3 H). ¹³C
NMR (75 Hz, CDCl3): δ = 164.3,
154.2, 147.7, 143.3, 138.4, 130.9, 129.3, 126.2, 118.6, 99.5, 18.9.
ESI-MS: m/z = 337 [M+ + 1]. Anal.
Calcd for C13H9IN2O: C, 46.45;
H, 2.70, N, 8.33. Found: C, 46.53; H, 2.75; N, 8.40.